Achilles Therapeutics plc reposted this
Immune Regulation and Tumour Immunotherapy Group led by Sergio Quezada at the Cancer Institute, UCL.
Really happy to share a link to our most recent preprint: https://lnkd.in/enDQ42fp In it we describe the development of a state-of-the-art immunogenicity predictor, laying the necessary foundation for the DECOD-Ag program. Great collaboration with Marc Mansour, Yardena Samuels, Charles Swanton, Sine Reker Hadrup, UCL Cancer Institute, and Achilles Therapeutics plc, funded by #EUHorizon2020 (EU Science, Research and Innovation).
